• Home
  • Conference Program

Conference Program


The preliminary program for the 2022 Clinical Cytometry Meeting & Course is posted below. Please check back for updates. All program times are listed in Eastern Time.

COURSE DATES
Friday, October 21 - Sunday, October 23

MEETING DATES
Sunday, October 23 - Tuesday, October 25


  Fri - Oct 21      Sat - Oct 22      Sun - Oct 23      Mon - Oct 24      Tue - Oct 25   


Tuesday, October 25th

7:00 - 8:00 AM
PEDIATRIC FLOW CYTOMETRY COMMITTEE MEETING
3rd Floor - Drummond East
7:30 - 8:15 AM
LYRIC GROUP GATHERING
3rd Floor - Drummond Centre
8:30 - 11:20 AM
PLENARY SESSION 4: MAPPING OUT MYELOID DIFFERENTIATION PATHWAYS USING FLOW CYTOMETRY: HOW KNOWLEDGE OF NORMAL MATURATION INFORMS DETECTION OF NEOPLASMS OF VARIOUS LINEAGES
Chair/Organizer: Sindhu Cherian, Nina Rolf
Ballroom West

8:30
CSI Case
Sarah Thang.

8:45
From Stem Cell Origin to the Mature Granulocyte
Xueyan Chen.

9:25
Q&A
.

9:30
Coffee Break
.

9:50
A Fork in the Road: When Maturation of Monocytic and Dendritic Cells Goes Wrong
Wei Wang.

10:30
Beyond Myelomonocytic Development: Tracing Erythroid Maturation Arrest and Aberrancies
Ulrika Johannsen.

11:10
Q&A
.
11:30 - 1:00 PM
TUESDAY LUNCHEON WORKSHOP 5: T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, THE INITIAL DIAGNOSIS AND MINIMAL MEASURABLE DISEASE DETECTION
3rd Floor - Drummond East

1
T-lymphoblastic Leukemia/Lymphoma, the Initial Diagnosis and Minimal Measurable Disease Detection - Part 1
Ben Hedley.

2
T-lymphoblastic Leukemia/Lymphoma, the Initial Diagnosis and Minimal Measurable Disease Detection - Part 2
Paul Mead.

TUESDAY LUNCHEON WORKSHOP 6: HOW TO SUPPORT TRIALS AND BIOMARKER RESEARCH IN CLINICAL FLOW CYTOMETRY LAB
3rd Floor - Salon 7

How to Support Trials and Biomarker Research in Clinical Flow Cytometry Lab - Part 1
Cherie Green.

How to Support Trials and Biomarker Research in Clinical Flow Cytometry Lab - Part 2
Jean Oak.

TUESDAY LUNCHEON WORKSHOP 7: INTERPRETATION OF H62 FOR ASSAY VALIDATION BY MEDICAL DIRECTORS
3rd Floor - Drummond Centre

Interpretation of H62 for Assay Validation by Medical Directors - Part 1
Dan Boyer.

Interpretation of H62 for Assay Validation by Medical Directors - Part 2
Min Shi.

TUESDAY LUNCHEON WORKSHOP 8: HOW TO IMPROVE YOUR DATA PART 2
3rd Floor - Drummond West

This workshop will cover issues related to instrumentation (both BD and Coulter), including how to set up your instrument, creating and checking compensation, carryover testing, maintenance, and troubleshooting.


How to Improve Your Data Part 2.1
Jolene Cardinali.

How to How to Improve Your Data Part 2.2
Amr Rajab.
1:00 - 4:00 PM
PLENARY SESSION 5: ADVANCEMENT IN B-LYMPHOBLASTIC LEUKEMIA, T-LYMOBLASTIC LEUKEMIA AND ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE
Chair/Organizer: Sanam Loghavi, Elizabeth Courville
Ballroom West

1:00
CSI Case: AML with RAM Phenotype
Julia Geyer.

1:15
B-ALL Updates
Michael Borowitz.

2:00
Coffee Break
.

2:30
Updates on MPAL, Including Lineage Switch
Brent Wood.

3:15
Genomic Characterization of Acute Leukemis of Ambiguous Lineage
Charles Mullighan.